US Patent Issued to YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM, UNIVERSITY OF RIJEKA FACULTY OF MEDICINE on July 14 for "Antibodies to NKP46 and constructs thereof for treatment of cancers and infections" (Israeli, Croatian Inventors)

ALEXANDRIA, Va., July 14 -- United States Patent no. 12,679,891, issued on July 14, was assigned to YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD (Jerusalem) and UNIVERSITY OF RIJEKA FACULTY OF MEDICINE (Rijeka, Croatia).

"Antibodies to NKP46 and constructs thereof for treatment of cancers and infections" was invented by Stipan Jonjic (Rijeka, Croatia), Ofer Mandelboim (Shoham, Israel), Orit Berhani (Jerusalem) and Shira Kahalon (Jerusalem).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides monoclonal antibodies that recognize human NKp46 with high affinity and specificity and do not block NKp46 binding to its natural ligands. The present invention fu...